VIR_logo_large.jpg
Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021
June 25, 2021 08:50 ET | Vir Biotechnology, Inc.
– Results demonstrate positive safety profiles and a reduction in HBsAg for two novel HBV therapies administrated as monotherapy or in combination with other agents – – Management to host conference...
22157.jpg
Global Biologics Safety Testing Market Report 2021-2027 - Increasing Biopharmaceutical Outsourcing & Emerging Markets Offer Lucrative Opportunities
June 24, 2021 04:08 ET | Research and Markets
Dublin, June 24, 2021 (GLOBE NEWSWIRE) -- The "Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood...
22157.jpg
Global COVID-19 Pipeline Insight Report 2021: Comprehensive Insights About 150+ Companies and 200+ Pipeline Drugs
June 23, 2021 07:28 ET | Research and Markets
Dublin, June 23, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This "COVID-19 - Pipeline Insight, 2021," report...
22157.jpg
Global Cancer Monoclonal Antibody Partnering Deal Terms and Agreements Report 2021
June 22, 2021 04:18 ET | Research and Markets
Dublin, June 22, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Cancer...
VIR_logo_large.jpg
GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab
June 21, 2021 07:06 ET | Vir Biotechnology, Inc.
– Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduces hospitalization and risk of death in adults with mild-to-moderate COVID-19 who are at high risk of progression...
22157.jpg
Global Therapeutic Proteins Market Report 2021: Market is Expected to Reach $155.06 Billion in 2025 at a CAGR of 12.1% - Forecast to 2030
June 16, 2021 04:03 ET | Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Therapeutic Proteins Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global Monoclonal Antibody Partnering Terms and Agreements Report 2021: Trends in Monoclonal Antibodies Dealmaking in the Biopharma industry Since 2014
June 09, 2021 06:53 ET | Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021" report has been added to ResearchAndMarkets.com's offering. The Global...
22157.jpg
$265 Billion Biotechnology Services Markets - Global Analysis & Forecasts, COVID-19 Impact and Recovery to 2025 & 2030
June 01, 2021 05:08 ET | Research and Markets
Dublin, June 01, 2021 (GLOBE NEWSWIRE) -- The "Biotechnology Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering....
VIR_logo_large.jpg
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
May 26, 2021 18:57 ET | Vir Biotechnology, Inc.
– Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalization or death in high-risk adult outpatients compared to placebo, based on interim results from Phase 3 COMET-ICE...
22157.jpg
Global Oncology/Cancer Drugs Market (2020 to 2027) - by Drug Class Type, Indication and Region
May 21, 2021 08:08 ET | Research and Markets
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Oncology/Cancer Drugs Market by Drug Class Type and Indication: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to...